These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8174718)

  • 1. Chlamydia trachomatis antibody testing is more accurate than hysterosalpingography in predicting tubal factor infertility.
    Dabekausen YA; Evers JL; Land JA; Stals FS
    Fertil Steril; 1994 May; 61(5):833-7. PubMed ID: 8174718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of Chlamydia trachomatis antibody testing in predicting tubal factor infertility.
    Veenemans LM; van der Linden PJ
    Hum Reprod; 2002 Mar; 17(3):695-8. PubMed ID: 11870122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlamydia trachomatis antibody titers and hysterosalpingography in predicting tubal disease in infertility patients.
    Meikle SF; Zhang X; Marine WM; Calonge BN; Hamman RF; Betz G
    Fertil Steril; 1994 Aug; 62(2):305-12. PubMed ID: 8034077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of Chlamydia trachomatis antibody testing as part of routine infertility investigations.
    Thomas K; Coughlin L; Mannion PT; Haddad NG
    Hum Reprod; 2000 May; 15(5):1079-82. PubMed ID: 10783356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of serum antibody to the chlamydial heat shock protein (CHSP60) as a diagnostic test for tubal factor infertility.
    Claman P; Honey L; Peeling RW; Jessamine P; Toye B
    Fertil Steril; 1997 Mar; 67(3):501-4. PubMed ID: 9091338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening strategies for tubal factor subfertility.
    den Hartog JE; Lardenoije CM; Severens JL; Land JA; Evers JL; Kessels AG
    Hum Reprod; 2008 Aug; 23(8):1840-8. PubMed ID: 18579509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydial serology and histerosalpingography in predicting tubal disease in infertility patients.
    Fiçicioğlu C; Api M
    Acta Eur Fertil; 1995; 26(3):109-12. PubMed ID: 9098470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia antibody testing in subfertile women.
    Land JA; den Hartog JE
    Drugs Today (Barc); 2006 Mar; 42 Suppl A():35-42. PubMed ID: 16683042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease.
    Moore DE; Spadoni LR; Foy HM; Wang SP; Daling JR; Kuo CC; Grayston JT; Eschenbach DA
    Lancet; 1982 Sep; 2(8298):574-7. PubMed ID: 6125729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia trachomatis immunoglobulin G3 seropositivity is a predictor of reproductive outcomes in infertile women with patent fallopian tubes.
    Steiner AZ; Diamond MP; Legro RS; Schlaff WD; Barnhart KT; Casson PR; Christman GM; Alvero R; Hansen KR; Geisler WM; Thomas T; Santoro N; Zhang H; Eisenberg E;
    Fertil Steril; 2015 Dec; 104(6):1522-6. PubMed ID: 26413816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining individual Chlamydia trachomatis IgG antibodies MOMP, TARP, CPAF, OMP2, and HSP60 for tubal factor infertility prediction.
    van Ess EF; Eck-Hauer A; Land JA; Morré SA; Ouburg S
    Am J Reprod Immunol; 2019 Mar; 81(3):e13091. PubMed ID: 30629310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of chlamydial antibody level for predicting tubal blockage among women undergoing hysterosalpingography in Lagos, Nigeria.
    Olaleye O; Olamijulo JA
    Int J Gynaecol Obstet; 2016 Jul; 134(1):33-6. PubMed ID: 27177510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of Chlamydia trachomatis-specific IgG antibody testing and hysterosalpingography for predicting tubal pathology and occurrence of pregnancy.
    Perquin DA; Beersma MF; de Craen AJ; Helmerhorst FM
    Fertil Steril; 2007 Jul; 88(1):224-6. PubMed ID: 17296194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide identification of Chlamydia trachomatis antigens associated with tubal factor infertility.
    Rodgers AK; Budrys NM; Gong S; Wang J; Holden A; Schenken RS; Zhong G
    Fertil Steril; 2011 Sep; 96(3):715-21. PubMed ID: 21742324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydia trachomatis IgG seropositivity is associated with lower natural conception rates in ovulatory subfertile women without visible tubal pathology.
    Coppus SF; Land JA; Opmeer BC; Steures P; Eijkemans MJ; Hompes PG; Bossuyt PM; van der Veen F; Mol BW; van der Steeg JW
    Hum Reprod; 2011 Nov; 26(11):3061-7. PubMed ID: 21926058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia serology screening in infertility patients.
    Keltz MD; Gera PS; Moustakis M
    Fertil Steril; 2006 Mar; 85(3):752-4. PubMed ID: 16500355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia trachomatis infection among Ghanaian women undergoing hysterosalpingography for suspected tubal factor infertility.
    Beyuo T; Oppong SA; Samba A; Beyuo VM
    Int J Gynaecol Obstet; 2019 Aug; 146(2):200-205. PubMed ID: 31162639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can diagnostic laparoscopy be avoided in routine investigation for infertility?
    Johnson NP; Taylor K; Nadgir AA; Chinn DJ; Taylor PJ
    BJOG; 2000 Feb; 107(2):174-8. PubMed ID: 10688500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilizing Chlamydia trachomatis IgG serology with HSG to diagnose tuboperitoneal-factor infertility.
    Bernstein RC; Yalcinkaya TM
    W V Med J; 2003; 99(3):105-7. PubMed ID: 14515433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of transvaginal hydrolaparoscopy in investigating infertile women with Chlamydia trachomatis infection.
    Shibahara H; Fujiwara H; Hirano Y; Suzuki T; Obara H; Takamizawa S; Idei S; Sato I
    Hum Reprod; 2001 Aug; 16(8):1690-3. PubMed ID: 11473964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.